Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Valion Bio (TIVC) Accumulated Depreciation & Amortization (2022 - 2025)

Valion Bio has reported Accumulated Depreciation & Amortization over the past 4 years, most recently at $15000.0 for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 400.0% year-over-year to $15000.0; the TTM value through Dec 2025 reached $15000.0, up 400.0%, while the annual FY2025 figure was $15000.0, 400.0% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $15000.0 at Valion Bio, up from $12000.0 in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $15000.0 in Q4 2025 and troughed at $1000.0 in Q1 2024.
  • A 4-year average of $4923.1 and a median of $3000.0 in 2023 define the central range for Accumulated Depreciation & Amortization.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: tumbled 83.33% in 2024 and later soared 1100.0% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $10000.0 in 2022, then fell by 20.0% to $8000.0 in 2023, then tumbled by 62.5% to $3000.0 in 2024, then soared by 400.0% to $15000.0 in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for TIVC at $15000.0 in Q4 2025, $12000.0 in Q3 2025, and $1000.0 in Q2 2025.